Inventor · disambiguated record
Jonathan David Garman
Also filed as: GARMAN JONATHAN D · GARMAN JONATHAN DAVID
30 granted patents·23 pending applications·262 citations·filing 1989–2022
96Inventor score
Top patents by PatentIndex Score
53 records- 0196US7858322B2Method of determining inhibition of binding to TRPM7 proteinNONO INC·Filed 2004·Granted Dec 28, 2010·83 cites·6 claims
- 0295US10206973B2Chloride salt of TAT-NR2B9cNONO INC·Filed 2015·Granted Feb 19, 2019·16 cites·34 claims
- 0393US11266714B2Chloride salt of TAT-NR2B9CNONO INC·Filed 2020·Granted Mar 8, 2022·2 cites·30 claims
- 0492US10251935B2Lyophilized formulation comprising tat-NR2B9C, histidine and trehaloseNONO INC·Filed 2016·Granted Apr 9, 2019·5 cites·10 claims
- 0591US7399467B2Antibodies for oncogenic strains of HPV and methods of their useARBOR VITA CORP·Filed 2004·Granted Jul 15, 2008·38 cites·38 claims
- 0690US10758589B2Chloride salt of TAT-NR2B9cNONO INC·Filed 2018·Granted Sep 1, 2020·3 cites·7 claims
- 0790US10300110B2Therapy for subarachnoid hemorrhage and ischemiaNONO INC·Filed 2015·Granted May 28, 2019·3 cites·1 claims
- 0889US8080518B2Co-administration of an agent linked to an internalization peptide with an anti-inflammatoryTYMIANSKI MICHAEL·Filed 2008·Granted Dec 20, 2011·13 cites·20 claims
- 0988US10912817B2Prelyophilized, lyophilized and reconstituted formulations comprising TAT-NR2B9C with d-amino acids, histidine and trehaloseNONO INC·Filed 2019·Granted Feb 9, 2021·2 cites·9 claims
- 1087US10206878B2Lyophilized formulation of TAT-NR2B9C with acetylation scavengerNONO INC·Filed 2015·Granted Feb 19, 2019·5 cites·16 claims
- 1186US8940699B2Model systems and treatment regimes for treatment of neurological diseaseTYMIANSKI MICHAEL·Filed 2010·Granted Jan 27, 2015·9 cites·19 claims
- 1284US10046060B2Co-administration of an agent linked to an internalization peptide with an anti-inflammatoryNONO INC·Filed 2016·Granted Aug 14, 2018·3 cites·3 claims
- 1383US7588911B2Assays for detecting inhibitors of binding between COX-2 and PDZ proteinsARBOR VITA CORP·Filed 2006·Granted Sep 15, 2009·7 cites·22 claims
- 1482US9610323B2Model systems and treatment regimes for treatment of neurological diseaseNONO INC·Filed 2015·Granted Apr 4, 2017·3 cites·12 claims
- 1581US8933013B2Co-administration of an agent linked to an internalization peptide with an anti-inflammatoryTYMIANSKI MICHAEL·Filed 2010·Granted Jan 13, 2015·4 cites·29 claims
- 1680US8288345B2Treating stroke and other diseases without inhibiting N-type calcium channelsBELMARES MICHAEL P·Filed 2008·Granted Oct 16, 2012·4 cites·7 claims
- 1779US11911438B2Chloride salt of TAT-NR2B9CNONO INC·Filed 2021·Granted Feb 27, 2024·0 cites·26 claims
- 1878US9433685B2Co-administration of an agent linked to an internalization peptide with an anti-inflammatoryNONO INC·Filed 2014·Granted Sep 6, 2016·2 cites·4 claims
- 1978US9061070B2Treating stroke and other diseases without inhibiting N-type calcium channelsBELMARES MICHAEL P·Filed 2012·Granted Jun 23, 2015·3 cites·7 claims
- 2077US8680137B2Agents and methods for treating ischemic and other diseasesSUN XIUJUN·Filed 2010·Granted Mar 25, 2014·6 cites·3 claims
- 2174US8324168B2Methods for treating painBELMARES MICHAEL P·Filed 2009·Granted Dec 4, 2012·1 cites·19 claims
- 2273US7459308B2Nucleic acid molecule encoding a CLASP-2 transmembrane proteinARBOR VITA CORP·Filed 2003·Granted Dec 2, 2008·2 cites·13 claims
- 2372US8748387B2Methods for treating painNONO INC·Filed 2012·Granted Jun 10, 2014·1 cites·20 claims
- 2471US4955685AActive fiber for optical signal transmissionSUN MICROSYSTEMS INC·Filed 1989·Granted Sep 11, 1990·18 cites·21 claims
- 2570US2022096383A1Lyophilized formulation of tat-nr2b9c with acetylation scavengerNONO INC·Filed 2021·Application pending·0 cites
- 2666US5119494AApplication address display window mapper for a sharable ms-dos processorATHENIX CORP·Filed 1990·Granted Jun 2, 1992·29 cites·6 claims
- 2763US9611315B2Antibodies for oncogenic strains of HPV and methods of their useARBOR VITA CORP·Filed 2014·Granted Apr 4, 2017·0 cites·31 claims
- 2862US2009047660A1Antibodies for oncogenic strains of HPV and methods of their useLU PETER·Filed 2008·Application pending·0 cites
- 2960US2024301003A1Plasmin-resistant peptides for improved therapeutic indexGARMAN JONATHAN DAVID·Filed 2022·Application pending·0 cites
- 3060US2019038760A1Co-administration of an agent linked to an internalization peptide with an anti-inflammatoryNONO INC·Filed 2018·Application pending·0 cites
- 3159US2010152294A1Assays For Detecting Inhibitors Of Binding Between COX-2 And PDZ ProteinsARBOR VITA CORP·Filed 2009·Application pending·0 cites
- 3259US2010120700A1Methods and compositions for treating cervical cancerARBOR VITA CORP·Filed 2009·Application pending·0 cites
- 3359US2006148711A1Molecular interactions in neuronsARBOR VITA CORP·Filed 2003·Application pending·0 cites
- 3457US2019231693A1Lyophilized formulation of tat-nr2b9c with acetylation scavengerNONO INC·Filed 2019·Application pending·0 cites
- 3555US9365620B2Methods for treating painNONO NC·Filed 2014·Granted Jun 14, 2016·0 cites·9 claims
- 3655US2012164629A1Antibodies For Oncogenic Strains Of HPV And Methods Of Their UseLU PETER·Filed 2012·Application pending·0 cites
- 3755US2023139826A1Combination treatment of stroke with plasmin-cleavable psd-95 inhibitor and reperfusionNONO INC·Filed 2021·Application pending·0 cites
- 3853US2023055441A1Plasmin-resistant peptides for treating stroke and related conditionsNONO INC·Filed 2021·Application pending·0 cites
- 3952US2008090770A1Modulation of Muc1 Mediated Signal TransductionBELMARES MICHAEL P·Filed 2004·Application pending·0 cites
- 4052US2007099199A1Methods and compositions for treating cervical cancerARBOR VITA CORP·Filed 2006·Application pending·0 cites
- 4151US2010209904A1Antibodies for oncogenic strains of HPV and methods of their useLU PETER·Filed 2010·Application pending·0 cites
- 4250US9566284B2Agents and methods for treating ischemic and other diseasesNONO INC·Filed 2013·Granted Feb 14, 2017·0 cites·3 claims
- 4350US2004229298A1Methods and compositions for treating cervical cancerFiled 2004·Application pending·0 cites
- 4447US2011039758A1Molecular Interactions in NeuronsARBOR VITA CORP·Filed 2010·Application pending·0 cites
- 4546US2005019841A1Modulation of signaling pathwaysARBOR VITA CORP·Filed 2003·Application pending·0 cites
- 4646US2003103992A1Clasp membrane proteinsARBOR VITA CORP·Filed 2001·Application pending·0 cites
- 4745US9073976B2ND2 peptides and methods of treating neurological diseaseNONO INC·Filed 2013·Granted Jul 7, 2015·0 cites·19 claims
- 4845US2002068302A1Clasp-4 transmembrane proteinFiled 2001·Application pending·0 cites
- 4944US2014162957A1Lyophilized formulation of tat-nr2b9cNONO INC·Filed 2013·Application pending·0 cites
- 5044US2002102267A1CLASP-5 transmembrane proteinFiled 2000·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jonathan David Garman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →